Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kuhnast

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
Tumor angiogenesis targeting using imaging agentsW A Weber, R Haubner, E Vabuliene, et al.
Nuclear Medicine and Biology|March 19, 2004
Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptideB Kuhnast, C Bodenstein, R Haubner, et al.
Organic & Biomolecular Chemistry|January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applicationsB Kuhnast, A El Hadri, R Boisgard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
Tumor angiogenesis targeting using imaging agentsW A Weber, R Haubner, E Vabuliene, et al.
Nuclear Medicine and Biology|March 19, 2004
Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptideB Kuhnast, C Bodenstein, R Haubner, et al.
Organic & Biomolecular Chemistry|January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applicationsB Kuhnast, A El Hadri, R Boisgard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
Pageof 1